4 départements de recherche
750 employés
45 nationalités
55 équipes de recherche
16 lauréats ERC
260 publications par an
24000 m² de laboratoires

Soutenez-nous via

Fondation universite de Strasbourg
IGBMC

Publications de l'IGBMC

  • Mitochondrial disease and amyloidosis in a patient with familial polyneuropathy.

    Gebus O(1), Fleury M(1), Chanson JB(1), Anheim M(1)(2), Tranchant C(1)(2), Echaniz-Laguna A(1).

    Eur J Neurol Nov 2018

  • Modeling gene-regulatory networks to describe cell fate transitions and predict master regulators.

    Cholley PE(1)(2), Moehlin J(1), Rohmer A(1), Zilliox V(1), Nicaise S(1), Gronemeyer H(1), Mendoza-Parra MA(1)(3).

    NPJ Syst Biol Appl 2 août 2018

  • Modulation of large dense core vesicle insulin content mediates rhythmic hormone release from pancreatic beta cells over the 24h cycle.

    Quinault A(1), Leloup C(1), Denwood G(2), Spiegelhalter C(3), Rodriguez M(4), Lefebvre P(5), Messaddeq N(3), Zhang Q(2), Dacquet C(6), Penicaud L(1), Collins SC(1)(3).

    PLoS One 15 mars 2018

  • Molecular Mechanisms and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

    Karam A(1)(2), Trottier Y(3)(4).

    Adv Exp Med Biol 2018

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

    Galluzzi L(1)(2)(3), Vitale I(4)(5), Aaronson SA(6), Abrams JM(7), Adam D(8), Agostinis P(9), Alnemri ES(10), Altucci L(11), Amelio I(12), Andrews DW(13)(14)(15), Annicchiarico-Petruzzelli M(16), Antonov AV(12), Arama E(17), Baehrecke EH(18), Barlev NA(19), Bazan NG(20), Bernassola F(21), Bertrand MJM(22)(23), Bianchi K(24), Blagosklonny MV(25), Blomgren K(26)(27), Borner C(28)(29), Boya P(30), Brenner C(31)(32), Campanella M(4)(5)(33)(34), Candi E(16)(21), Carmona-Gutierrez D(35), Cecconi F(4)(36)(37), Chan FK(38), Chandel NS(39), Cheng EH(40), Chipuk JE(6), Cidlowski JA(41), Ciechanover A(42), Cohen GM(43), Conrad M(44), Cubillos-Ruiz JR(45)(46), Czabotar PE(47)(48), D'Angiolella V(49), Dawson TM(50)(51)(52)(53), Dawson VL(50)(51)(53)(54), De Laurenzi V(55), De Maria R(56), Debatin KM(57), DeBerardinis RJ(58), Deshmukh M(59), Di Daniele N(60), Di Virgilio F(61), Dixit VM(62), Dixon SJ(63), Duckett CS(64), Dynlacht BD(65)(66), El-Deiry WS(67)(68), Elrod JW(69), Fimia GM(70)(71), Fulda S(72)(73)(74), Garcia-Saez AJ(75), Garg AD(9), Garrido C(76)(77)(78), Gavathiotis E(79)(80)(81)(82), Golstein P(83), Gottlieb E(42)(84), Green DR(85), Greene LA(86), Gronemeyer H(87)(88)(89)(90), Gross A(91), Hajnoczky G(92), Hardwick JM(93), Harris IS(94), Hengartner MO(95), Hetz C(96)(97)(98), Ichijo H(99), Jaattela M(100), Joseph B(101), Jost PJ(102), Juin PP(103)(104)(105)(106), Kaiser WJ(107), Karin M(108)(109)(110)(111), Kaufmann T(112), Kepp O(113)(114)(115)(116)(117)(118), Kimchi A(17), Kitsis RN(80)(81)(82)(119)(120), Klionsky DJ(121)(122), Knight RA(12), Kumar S(123), Lee SW(124), Lemasters JJ(125)(126), Levine B(127)(128)(129), Linkermann A(130), Lipton SA(131)(132)(133), Lockshin RA(134)(135), Lopez-Otin C(136), Lowe SW(137)(138), Luedde T(139), Lugli E(140)(141), MacFarlane M(12), Madeo F(35)(142), Malewicz M(12), Malorni W(143), Manic G(4)(5), Marine JC(144)(145), Martin SJ(146), Martinou JC(147), Medema JP(148)(149), Mehlen P(150)(151)(152)(153)(154)(155), Meier P(156), Melino S(157), Miao EA(158)(159)(160), Molkentin JD(161), Moll UM(162), Munoz-Pinedo C(163), Nagata S(164), Nunez G(165)(166), Oberst A(167)(168), Oren M(169), Overholtzer M(170), Pagano M(66)(171)(172), Panaretakis T(173)(174), Pasparakis M(175)(176), Penninger JM(177), Pereira DM(178), Pervaiz S(179)(180)(181), Peter ME(182)(183), Piacentini M(4)(70), Pinton P(61)(184)(185), Prehn JHM(186), Puthalakath H(187), Rabinovich GA(188)(189), Rehm M(190)(191), Rizzuto R(192), Rodrigues CMP(193), Rubinsztein DC(194), Rudel T(195), Ryan KM(84), Sayan E(196), Scorrano L(197)(198), Shao F(199), Shi Y(200)(201)(202), Silke J(48)(203), Simon HU(112), Sistigu A(56)(204), Stockwell BR(205)(206), Strasser A(47), Szabadkai G(192)(207)(208), Tait SWG(84), Tang D(209)(210)(211)(212)(213)(214), Tavernarakis N(215), Thorburn A(216), Tsujimoto Y(217), Turk B(218)(219), Vanden Berghe T(22)(23), Vandenabeele P(22)(23), Vander Heiden MG(220)(221)(222), Villunger A(223), Virgin HW(224), Vousden KH(208), Vucic D(225), Wagner EF(226), Walczak H(227), Wallach D(228), Wang Y(229), Wells JA(230), Wood W(231), Yuan J(94)(232), Zakeri Z(233), Zhivotovsky B(101)(234), Zitvogel L(114)(235)(236)(237), Melino G(12)(21), Kroemer G(238)(239)(240)(241)(242)(243)(244).

    Cell Death Differ 23 janvier 2018

  • Molecular structure of promoter-bound yeast TFIID.

    Kolesnikova O(1)(2)(3)(4), Ben-Shem A(1)(2)(3)(4), Luo J(5), Ranish J(5), Schultz P(6)(7)(8)(9), Papai G(10)(11)(12)(13).

    Nat Commun 7 novembre 2018

  • Mu-opioid receptors in nociceptive afferents produce a sustained suppression of hyperalgesia in chronic pain.

    Severino A(1)(2)(3), Chen W(1)(2), Hakimian JK(3), Kieffer BL(4), Gaveriaux-Ruff C(5)(6)(7)(8)(9), Walwyn W(3), Marvizon JCG(1)(2).

    Pain Aug 2018

  • Multiple inputs ensure yeast cell size homeostasis during cell cycle progression.

    Garmendia-Torres C(1), Tassy O(1), Matifas A(1), Molina N(1), Charvin G(1).

    Elife 4 juillet 2018

Imprimer Envoyer

Université de Strasbourg
INSERM
CNRS

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr